Red Blood Cells, Concentrated


Combined with:

Thymoglobulin

Indications and Reactions:

Role Indications Reactions
Secondary
Maternal Exposure Timing Unspecified 23.9%
Partial Seizures 11.9%
Product Used For Unknown Indication 9.0%
Diabetes Mellitus 7.5%
Anaemia Postoperative 6.0%
Hypoalbuminaemia 6.0%
Premedication 6.0%
Tissue Sealing 6.0%
Constipation 4.5%
Hypertension 4.5%
Anaemia 1.5%
Anaemia Prophylaxis 1.5%
Anxiety 1.5%
Arteriovenous Graft Site Haemorrhage 1.5%
Benign Prostatic Hyperplasia 1.5%
Cerebrovascular Accident 1.5%
Coronary Artery Disease 1.5%
Diabetic Retinal Oedema 1.5%
Epilepsy 1.5%
Fungal Infection 1.5%
Creutzfeldt-jakob Disease 33.3%
Disseminated Intravascular Coagulation 8.3%
Hyperkalaemia 8.3%
Pancytopenia 8.3%
Platelet Count Decreased 8.3%
Premature Baby 8.3%
Pulmonary Oedema 8.3%
Toxic Epidermal Necrolysis 8.3%
White Blood Cell Count Decreased 8.3%
Concomitant
Product Used For Unknown Indication 23.3%
Prophylaxis 14.1%
Aplastic Anaemia 12.8%
Infection Prophylaxis 6.6%
Iron Overload 6.4%
Premedication 5.9%
Myelodysplastic Syndrome 4.9%
Bone Marrow Conditioning Regimen 4.1%
Hypertension 3.1%
Acute Myeloid Leukaemia 3.0%
Prophylaxis Against Graft Versus Host Disease 3.0%
Antifungal Prophylaxis 2.7%
Gastritis Prophylaxis 1.5%
Constipation 1.4%
Diabetes Mellitus 1.4%
Coronary Artery Bypass 1.4%
Prophylaxis Against Gastrointestinal Ulcer 1.3%
Antibiotic Prophylaxis 1.2%
Antiviral Prophylaxis 1.1%
Acute Lymphocytic Leukaemia 1.0%
General Physical Health Deterioration 15.5%
Pneumonia 8.5%
Malnutrition 7.3%
Renal Failure Chronic 7.3%
Renal Impairment 6.7%
Pain 5.2%
Pyrexia 5.2%
Injury 4.9%
Sepsis 4.9%
Diarrhoea 3.7%
Foot Amputation 3.7%
Pancreatitis Acute 3.7%
Anaemia 3.4%
Blood Bilirubin Increased 3.4%
Thrombocytopenia 3.4%
Neutropenia 3.0%
Viith Nerve Paralysis 2.7%
White Blood Cell Count Decreased 2.7%
Alopecia 2.4%
Blood Lactate Dehydrogenase Increased 2.4%

Drug Data